Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme - A report from the EORTC 26981/22981 NCI-C CE3 intergroup study

LM (Leida) Lamers, R Stupp, Martin van den Bent, Maiwenn Al, T Gorlia, JB Wasserfallen, N Mittmann, SJ Seung, R Crott, Carin A. de Groot

Research output: Contribution to journal › Article › Academic › peer-review

45 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme - A report from the EORTC 26981/22981 NCI-C CE3 intergroup study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science